Manufacturing CNS Medication
There are many different types of drugs that work on the central nervous system (CNS), including anesthetics, anticonvulsants, antiemetics, anti-Parkinson agents, stimulants, muscle relaxants and sedatives.
As many of these products can cause serious side-effects from occupational exposure, containment is a key aspect to consider during the manufacturing process. As containment experts, we not only offer the largest variety of solutions for contained processing, but also unrivaled experience in identifying the most appropriate solution based on a containment risk analysis.
Delivering medication to the central nervous system remains challenging, which is why the industry continues to look at alternative methods of administration, such as the intranasal route or the use of colloidal drug carriers.
For inhalable versions, homogeneity and stability are key factors. Our dry powder blending, spray drying and particle engineering capabilities ensure that the production of free-flowing, aerodynamic particles at the correct size is achievable at the scale you need.
We also supply proven solutions for solid dispersions for bioavailability enhancement, such as extrusion, spheronization and a complete engineering service from system design to process integration and optimization.
Furthermore, we understand that during early research and development (R&D), the availability of the active ingredient is often limited. As such, there is an absolute requirement for process equipment that is capable of producing just a few hundred grams of finished product to fast-track new drug formulations.
Designed for small-scale and R&D applications, particularly with potent actives, the PharmaConnect®-PLUS — based on the established combination of a single control unit with a diverse range of process modules — is GEA’s modular granulation, extrusion/spheronization and blending system that offers an unbeatable range of process types and capacities, and also integrates with the Flexstream range of fluidized bed processors.
In addition, the ConsiGma® 4.0 platform combines Quality by Design (QbD) principles with DoE to explore and optimize a wide range of process parameters with less product in a shorter time frame.
Produkte und Technologien
Zeigt 4 von 27 an
Analyse-, Inline Steuer- und Messvorrichtungen
Durch die Verbindung von Prozessüberwachung per Online-Analysetools mit soliden Verfahrenstechnikprinzipien und fortschrittlichen Prozessmodellierungsmethoden können Prozesse aktiv überwacht werden, um Eingabevariationen zu kompensieren.
CIP/SIP-Lösungen
Innovative CIP-Konzepte von GEA erfüllen umfassende hohe Normen. Unsere Experten garantieren die Produktsicherheit an jeder Stelle des Prozesses. Jede Aktualisierung wird an die individuellen lokalen Bedingungen und Anforderungen der Kunden angepasst und führt zu erheblichen Einsparungen.
Contained Materials Handling Systems
Contained Materials Handling solutions for Primary and Secondary Pharmaceuticals and Healthcare. With extensive experience within the generics sector, supply a wide range of technologies and equipment that improve and enhance the efficiency and performance of Oral Solid Dosage production.
Continuous Direct Compression Line
The ConsiGma® DC for direct compression is the latest expansion of GEA's continuous portfolio for cost effective, compact, high yield manufacturing systems. It offers a robust and flexible manufacturing method for a wide range of products.
Downloads
GEA Insights
The breakthrough that changed spray drying
In 1976, NIRO engineers responded to a competitive challenge by rethinking what spray drying could do. Their idea became the multi-stage dryer MSD. Fifty years later, the same fundamental principle helps turn liquids into the powders used in essential nutrition products and important medicines around the world. Refined through decades of engineering expertise, customer insight and continuous development, MSD is a story of innovation with lasting impact.
Das Ganze im Blick: Wie Anlagen dauerhaft besser laufen
Eine effiziente Maschine macht noch keine effiziente Produktion. Echte Verbesserungen beginnen oft damit, den Blick über die einzelnen Anlagenelemente hinaus zu richten und zu verstehen, wie sich Prozesse, Energiesysteme und betriebliche Entscheidungen gegenseitig beeinflussen. Ein solcher ganzheitlicher Ansatz hilft beim Identifizieren von Potenzialen, die sonst verborgen bleiben.
Wie eine neue Ventiltechnologie die Produktion von Lebensmitteln und Getränken verändert
In der Lebensmittel- und Getränkeindustrie werden Ventile traditionell mit Druckluft betrieben. Die GEA Hydract®-Antriebstechnologie betätigt Ventile dagegen mit Wasser in einem geschlossenen, digital gesteuerten Kreislauf. Das Ergebnis: Ventile lassen sich präzise in jeder gewünschten Position halten und in fein abgestuften Schritten steuern. Dadurch sinken der Energieverbrauch und gleichzeitig steigt die Prozesskontrolle erheblich.
